Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Promising OS and PFS data have been shown, especially in non-squamous taxane-nave NSCLC (n=42), with a median PFS of 6.4 months (95% CI, 4.5 to 10.5) and median OS of 16.3 months (95% CI, 11.5 to NR), compared to 3.5 months (95% CI, 2.7 to 5.3) and 11.2 months (95% CI, 8.3 to 13.7), respectively, in all NSCLC subtypes [87]
Acid-Resistant Capsule Technology This changes everything
Rapid detection of inducers of enzymes that protect against carcinogens
Beyond that, this power-packed antioxidant contributes significantly to improving different chronic illnesses
US$ 27.16
US$ 23.11
US$ 29.33
US$ 21.81
